As you see your portfolio drift away in the wind this time every year on low volume, dont you ask yourself why not follow the herd and sell in May and go away?

As Labor Day weekend approaches and people are getting back to work, I expect to see the smart money taking advantage of the undervalued shares out there.

Two compnies that are poised to have large gains in the second half of the year are: iCo Theraputics (V.ICO) and Aroway Energy (V.ARW)

Quick snap shot: iCo- Huge valuation gap. Currently trades at $17.7M market cap. Looking at a counterpart currently undertaking phase 2 results trades at a $60M marketcap, despite its trials being halted. I expect to see iCo shift closer towards that valuation with interm phase 2 data due out shortly on their 007 drug(DME). If the phase 2 results prove to be successful and with the eye space being the hottest subsector in healtcare you could realisticly see a valuation of $200M marketcap by year end. For more information check out: http://www.icotherapeutics.com/

Quick snap shot: ARW- Current production 650 boe/d (90% oil) with 200 boe/d of nat gas shut in due to low prices. Aroway and its JV partner have assembled an impressive land package of 121 sections, surrounded by many oil and gas majors. Aroway is drilling 8 wells this summer and should have results out for 4 of them shortly. Aroway expects to exit 2012 with 1200 boe/d of production and hopes that level could attract some buyers as there exit strategy has always been to get acquired by one of the majors. For more information check out: http://www.arowayenergy.com/